Dermatol. praxi. 2016;10(3):152-154 | DOI: 10.36290/der.2016.035

Sézary syndrome and primary cutaneous CD30+ lymphoproliferative disorders

MUDr. Eliška Langerová
FN u sv. Anny a LF MU v Brně

Sézary syndrome (SS) is a rare, but agressive variant of T-cell lymphoma. It is characterised by: erytrodermy, generalised lymfadenopathy, presence of Sézary cells in periferal blood (more than 1 000/mm3). Medical care of patient with SS is always multidisciplenary, including hematooncologists. Despite SS primary cutaneous CD 30+ lymfoproliferative deseases are indolent and are the second most common type of cutaneous T-cell lymhomas (CTCL). This group of CTCL includes primary cutaneous anaplastic large cell CD30+ T-cell lymphoma (C- ALCL) a lymphomatoid papulosis (LyP). Despite its benign course all the patients should be follwed-up lifelong, becaues of the risk of systemic progression or development of other cutaneous T-cell lymhoma.

Keywords: Sézary syndrome, primary cutaneous anaplastic large cell CD30+ T-cell lymphoma, lymphomatoid papulosis

Published: October 1, 2016  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Langerová E. Sézary syndrome and primary cutaneous CD30+ lymphoproliferative disorders. Dermatol. praxi. 2016;10(3):152-154. doi: 10.36290/der.2016.035.
Download citation

References

  1. Willemze R, Jaffe ES, et al. WHO-EORTC classification for cutaneous lymphomas; Blood 2005; 105(10): 3768-3785. Go to original source... Go to PubMed...
  2. Delon Liu, et al. Anaplastic Large Cell Lymphoma; dostupný z : Medscape.org: 8/2013.
  3. H Stein, et al. CD 30+ anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features; Blood 2000; 96(12): 3681-3695. Go to original source...
  4. Parlette EC, Tabor CA. CD 30+, large T-cell lymphoma: Diagnostic distinction and management; DOJ 2006; 12(6): 8. Go to original source...
  5. Machovcová A. Kožní lymfomy; Czechopress agency, Praha 2009: 3-18 (reprint).
  6. Kempf W, et al. EORTC, ISCL, and USCLC consesnus recommendation for the treatment of primary cutaneous CD 30 positive lymfoproliferatie disorders: lymphomatoid papulosis and primary cutaenous anaplastic large-cell lymphoma; Blood 2011; 118(15): 4024-4033. Go to original source... Go to PubMed...
  7. Willemze R, Dreyling M. Primary cutaneous lymphomas: ESMO Clinical Practice Guidlines for diagnosis, teratment and follow-up; Anals of Oncology 2010; 21(5): 177-180. Go to original source... Go to PubMed...
  8. Pinter-Brown LC. Cutaneous T-Cell Lymphoma; dostupný z: Medscape.org.




Dermatology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.